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Utrecht, the NetherlandsThe times are gone in which we all thought that the heart
was just a mechanical pump and adipose tissue was where
you stored your excess calories. Both the heart and adipose
tissue have been recognized as part endocrine organ (1,2),
while the interplay between these organs, and especially the
effects of natriuretic peptides on adipose tissue, is receiving
deserved attention (3).
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The natriuretic peptides atrial natriuretic peptide (ANP),
brain natriuretic peptide (BNP), and its nonactive peptide N-
terminal pro–B-type natriuretic peptide (NT-proBNP) have
all been studied extensively in relation to the treatment and
diagnosis of hypertension and especially to heart failure in the
case of BNP and NT-proBNP (4–7). Unexpectedly, in recent
years, the effects of the natriuretic peptides have been found
to extend beyond the vascular system.
ANP and BNP inﬂuence adipose tissue through binding
to the natriuretic peptide receptors (NPRs). Binding of
the natriuretic proteins to the NPR-A receptor leads to
enhanced lipolysis (ANP > BNP) (8) and adiponectin
secretion (9), whereas binding to the NPR-C or clearance
receptor leads to degradation of the natriuretic proteins (4).
Because observational studies found an inverse relation
between plasma natriuretic peptide levels and body mass
index (10), it was presumed that this relation could be
explained by enhanced clearance of the natriuretic peptide
via the NPR-C receptor in adipose tissue. A new problem
arose when it was found that the nonactive peptide
NT-proBNP, which is secreted simultaneously with BNP,
had the same inverse relation with body mass index while
not being cleared from the circulation by the NPR-C
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relevant to the contents of this paper to disclose.In this issue of the Journal, Neeland et al. (11) show, using
convincing methods, a relation between both higher plasma
BNP and NT-proBNP levels and less visceral adipose tissue,
liver fat, and increased lower body fat, independent of age, sex,
race, and markers of adiposity. Some of the ﬁndings in the
paper receive little or no attention: for example, the nonactive
peptideNT-proBNPhas a stronger inverse relation to visceral
fat and liver fat than BNP. Because BNP is cleared from the
circulation by the NPR-C receptors, which are especially
abundant in the visceral adipose tissue compartment (12),
should the stronger relation between NT-proBNP, and for
example visceral fat, be seen as a proxy and more accurate
representation of the relation between BNP and visceral fat
which is just diluted by the clearance of BNP via the NPR-C
receptor while still having its major beneﬁcial effects through
the NPR-A receptor? The study by Neeland et al., however,
will not answer this question because it suffers from a problem
that often occurs with observational etiologic studies: the
precise causal relations remain unclear and, as always, further
studies are needed.
One of the remaining questions is the precise role of
adipose tissue. ANP reduces low-grade inﬂammation in
adipose tissue (13), whereas the adipose tissue itself is
instrumental in the regulation of plasma natriuretic peptide
levels via the insulin-dependent expression of NPR-C (12).
Not surprisingly, insulin resistance is associated with lower
natriuretic peptide levels (14), which may also be an expla-
nation for the relation Neeland et al. (11) found between
natriuretic peptides and liver fat after adjustment for visceral
fat. Because rapid reductions in adipose tissue, such as after
bariatric surgery, are associated with an increase in the
natriuretic peptides (15), and the expression of NPR-C on
adipose tissue probably does not completely explain the
relation between adipose tissue and plasma natriuretic
peptide levels (16), we could speculate on the existence of
a possible adipose tissue–derived feedback mechanism on
the production of natriuretic peptides. Perhaps the way to
a man’s heart is through his stomach?
Finally, the least scientiﬁc but for some the most obvious
question remains: the teleological one. Towhat purposemight
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762we have such a connection between adipose tissue and the
heart and vice versa? Although nature is not always obliged to
give us these answers, we should ask the questions. Or to use
a Dutch proverb: You have “No,” you can get “Yes.”
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